Healthcare company Johnson & Johnson conditionally won European Commission approval on Thursday to buy rival medical device maker Guidant Corp. for $25.4 billion in cash and stock.
*For more on this story,
read the full Reuters article.
Healthcare company Johnson & Johnson conditionally won European Commission approval on Thursday to buy rival medical device maker Guidant Corp. for $25.4 billion in cash and stock.
*For more on this story,
read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99